Verisk Analytics, Inc. (VRSK) Stock Price & Analysis
Verisk Analytics, Inc. (VRSK) closed at USD 203.33 on Thursday, October 22, 2026, up 5.71% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 192.34; the Oct 22, 2026 session ranged USD 195.58–203.47 on volume of 1,457,801 shares. Market capitalization is $26.46B, with a 52-week range of USD 155.94–237.85 (NMS). Source: Nexqual, retrieved October 23, 2026 at 09:28 UTC.
Also available as compact Markdown for AI agents: nexqual.com/VRSK.md
Key facts (VRSK)
- Last four reported quarters (through Jun 30, 2026): revenue $3.14B, net income $886M (28.2% margin), free cash flow $1.24B (SEC filings).
- Valuation: P/E 29.9x (avg 44.3x at the last 3 fiscal year-ends), EV/EBITDA 18.6x, net debt $3.92B.
- 5 of 80 tracked superinvestors hold VRSK (13F, Q2 2026): 0 new, 2 added, 2 reduced, 1 unchanged.
- Analysts: Buy (mean 2.21 on a 1–5 scale) (19 analysts), mean target USD 226.47 (range 195–260).
- Total return with dividends: 1Y -12.5% vs S&P 500 +14.9%; 5Y -1.6% vs S&P 500 +80.3%.
- Next earnings: 2026-11-05, EPS estimate USD 1.92, revenue estimate $806M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (VRSK)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $2.46B | $2.50B | $2.68B | $2.88B | $3.07B | $3.14B |
| Gross profit | $1.61B | $1.67B | $1.80B | $1.98B | $2.15B | — |
| Operating income | $911M | $1.41B | $1.13B | $1.25B | $1.34B | $1.38B |
| Net income | $666M | $954M | $615M | $958M | $908M | $886M |
| EPS (diluted) | $4.08 | $6.00 | $4.17 | $6.71 | $6.48 | — |
| Free cash flow | $887M | $784M | $831M | $920M | $1.19B | $1.24B |
| Gross margin | 65.3% | 67.0% | 67.3% | 68.7% | 69.9% | — |
| Operating margin | 37.0% | 56.3% | 42.2% | 43.5% | 43.7% | 43.9% |
| Net margin | 27.1% | 38.2% | 22.9% | 33.3% | 29.6% | 28.2% |
| Revenue growth | +8.5% | +1.4% | +7.4% | +7.5% | +6.6% | — |
| Cash + short-term investments | $112M | $113M | $303M | $291M | $2.18B | — |
| Total debt | $4.29B | $5.14B | $2.90B | $3.61B | $6.28B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (VRSK)
P/E 29.9x · P/S 8.4x · EV/EBITDA 18.6x · EV/Sales 9.7x · P/FCF 21.4x · FCF yield 4.67% · Earnings yield 3.35% · Dividend yield (paid, TTM) 0.97% · Buyback yield (TTM) 7.16% · Net debt $3.92B · EV $30.4B
P/E at fiscal year-ends: Dec 2025 34.5x, Dec 2024 41.1x, Dec 2023 57.3x.
Superinvestors (SEC 13F-HR, Q2 2026) (VRSK)
5 of 80 tracked investors hold VRSK. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Jensen Investment Management | 1.65% | $68.1M | Reduced -21.3% | |
| Torray Funds | 0.59% | $4.4M | Reduced -0.3% | |
| Thomas Gayner | Markel Group | 0.21% | $28.0M | Unchanged |
| Lindsell Train | 0.06% | $1.7M | Added +13.1% | |
| Yacktman Asset Management | 0.05% | $3.8M | Added +43.4% |
Analysts (VRSK)
Consensus Buy (mean 2.21 on a 1–5 scale), 19 analysts; mean target USD 226.47 (low 195, high 260).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-13 | BMO Capital | Target lowered | Outperform | $248 → $217 |
| 2026-10-13 | Morgan Stanley | Target lowered | Equal-Weight | $235 → $215 |
| 2026-09-08 | Barclays | Target lowered | Overweight | $275 → $225 |
| 2026-07-30 | UBS | Target raised | Neutral | $220 → $235 |
| 2026-07-30 | Evercore ISI Group | Target raised | In-Line | $222 → $223 |
| 2026-07-30 | Wells Fargo | Target raised | Overweight | $240 → $260 |
| 2026-07-23 | Jefferies | Upgrade | Hold → Buy | $192 → $235 |
Total return (dividends reinvested) (VRSK)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -12.5% | -1.6% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -12.6% | -0.3% |
| Volatility (annualized) | 36.8% | 26.7% |
| Max drawdown | -32.9% (Oct 2025→May 2026) | -48.7% (Jun 2025→May 2026) |
VRSK analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $1.92 | $1.95 | -1.2% | $806.2M | 15 |
| Next quarter (ends Dec 2026) | $1.97 | $1.98 | -0.2% | $824.9M | 15 |
| Current fiscal year (ends Dec 2026) | $7.70 | $7.67 | +0.5% | $3.22B | 19 |
| Next fiscal year (ends Dec 2027) | $8.70 | $8.68 | +0.2% | $3.44B | 19 |
Key Statistics (as of October 23, 2026 at 09:28 UTC)
| Price | USD 203.33 |
|---|---|
| Change | ▲ 5.71% (up) |
| Previous Close | USD 192.34 |
| Open | USD 196.75 |
| Day Range | USD 195.58 – 203.47 |
| 52-Week Range | USD 155.94 – 237.85 |
| Volume | 1,457,801 shares |
| Market Cap | $26.46B |
| Exchange | NMS |
Technical Analysis (VRSK)
Nexqual's technical model rates VRSK "BUY" based on 5 bullish and 3 bearish signals across 127 daily candles, as of October 23, 2026 at 09:28 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 73.5 (overbought) |
| vs SMA50 | Above (USD 180.36) |
| MACD | 4.83 (positive) |
Analyst Ratings (VRSK)
Wall Street analysts rate VRSK "Buy" based on 19 analysts, with a mean price target of USD 226.47 (range USD 195–260), per Nexqual as of October 23, 2026 at 09:28 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 19 |
| Mean Target | USD 226.47 |
| High Target | USD 260 |
| Low Target | USD 195 |
| Buy / Hold / Sell | 11 / 8 / 0 |
Earnings (VRSK)
| Next Earnings Date | 2026-11-05 |
|---|---|
| EPS Estimate | USD 1.92 |
| Revenue Estimate | $806.20M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 1.98 vs est 1.93 ▲ beat |
| 2026-03-31 | USD 1.82 vs est 1.74 ▲ beat |
| 2025-12-31 | USD 1.82 vs est 1.61 ▲ beat |
| 2025-09-30 | USD 1.72 vs est 1.7 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:28 UTC.
Financials & Fundamentals (VRSK)
| Total Revenue | $3.14B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +4.40% |
| Gross Margin | +70.18% |
| Operating Margin | +45.11% |
| Profit Margin | +28.24% |
| Current Ratio | 1.01 |
| Total Cash | $552.20M |
| Total Debt | $4.62B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $1.24B (39.4% of revenue) |
Source: Nexqual, October 23, 2026 at 09:28 UTC.
Financial Health Score (VRSK)
Nexqual rates Verisk Analytics, Inc.'s overall financial health "Solid" across five dimensions, as of October 23, 2026 at 09:28 UTC.
| Growth | Solid — Revenue +7% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 70%, operating 45% (last 12 months) |
| Balance Sheet | Mixed — $551M cash and investments vs $4.47B debt (Jun 2026, SEC) |
| Cash Flow | Strong — FCF $1.24B (last 4 quarters to Jun 2026, SEC), 39% margin |
| Efficiency | Mixed — No data |
Ownership (VRSK)
| Insider Ownership | +0.27% |
|---|---|
| Institutional Ownership | +101.49% |
| Shares Outstanding | 130.16M |
| Float | 129.76M |
| Short % of Float | +3.71% |
Source: Nexqual, October 23, 2026 at 09:28 UTC.
Leadership (VRSK)
Verisk Analytics, Inc. is led by Lee M. Shavel, CEO, President & Director, per Nexqual as of October 23, 2026 at 09:28 UTC.
| CEO, President & Director | Lee M. Shavel |
|---|---|
| Executive VP & CFO | Elizabeth D. Mann |
| CTO & Interim Chief Information Officer | Jeff Negrete |
| Senior Vice President of Finance & Investor Relations | Stacey Jill Brodbar |
| Chief Marketing Officer | Melissa Hendricks |
Major Backers & Investors (VRSK)
Notable institutional backers of Verisk Analytics, Inc. include Alliancebernstein L.P., Capital International Investors, BAMCO Inc., according to Nexqual as of October 23, 2026 at 09:28 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Alliancebernstein L.P. | 4.62% |
| Capital International Investors | 4.06% |
| BAMCO Inc. | 3.61% |
| Morgan Stanley | 3.53% |
| WASHINGTON MUTUAL INVESTORS FUND | 2.13% |
| BARON SELECT FUNDS-Baron Partners Fund | 1.88% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 11.43% |
| BlackRock | 7.93% |
| State Street | 4.43% |
| Geode Capital | 3.07% |
Source: Nexqual, October 23, 2026 at 09:28 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| EFX | Equifax, Inc. | USD 187.14 | ▲ 6.59% |
| BAH | Booz Allen Hamilton Holding Cor | USD 78.57 | ▲ 4.7% |
| FCN | FTI Consulting, Inc. | USD 157.59 | ▲ 5.5% |
| HURN | Huron Consulting Group Inc. | USD 193.35 | ▲ 5.47% |
| ICFI | ICF International, Inc. | USD 93.33 | ▲ 3.76% |
| CRAI | CRA International,Inc. | USD 200.94 | ▲ 9.59% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:28 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt